GDUFA Collections Fell Short In FY 2021
Biosimilars Came Closer While PDUFA Collections Exceeded Target
Executive Summary
The US FDA reports that GDUFA met all of its 11 performance enhancement goals in FY 2021, while BsUFA is on track to meet 16 of 27 of its performance enhancement goals.